The placebo effect and its determinants in osteoarthritis: meta-analysis of randomised controlled trials
By Weiya Zhang, J. Robertson, A. Jones, Paul A. Dieppe, M. Doherty. Annals of the Rheumatic Diseases, 2008
626 citations recorded by the source corpus.
Subfields: Cognitive Neuroscience, Complementary and alternative medicine, Physiology
View Paper: https://www.semanticscholar.org/paper/0517c146c6a57c346a855b8bfcc5c66472150192
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- H. V. van Schie
- S. Bierma-Zeinstra
- J. Verhaar
- Xavier Chevalier
- Frank P. Luyten
- P. Goupille
- C. N. Dijk
- D. Scott
Citations in the corpus
- Platelet-rich plasma injection for chronic Achilles tendinopathy: a randomized controlled trial. (2010, background): “Another possible explanation for the improvement in the placebo group might be that the placebo response is amplified when a treatment is invasive and raises high expectations.(33) This has also been demonstrated previously in a study on the value of injection therapy for the treatment of tendinopat”
- Single, intra-articular treatment with 6 ml hylan G-F 20 in patients with symptomatic primary osteoarthritis of the knee: a randomised, multicentre, double-blind, placebo controlled trial (2009, background): “The placebo effect in osteoarthritis treatment has been re-evaluated in a recent meta-analysis showing that it induces significant pain relief, especially in trials involving intra-articular injections.(21) Furthermore, because the actual therapeutic effect of arthrocentesis (with synovial fluid asp”